A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis. - Liu, Yaxin; Wang, Wei; Yin, Rutie; Zhang, Youzhong; Zhang, Yu; Zhang, Keqiang; Pan, Hongming; Wang, Ke; Lou, Ge; Li, Guiling; Zhang, Ruyan; Li, Kun; et al. (BMC Medicine, 2023)